BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Shortcuts aren’t common in medicine, but BrainsWay may have found an effective one for treating major depressive disorder. The company’s Deep Transcranial Magnetic Stimulation (Deep TMS) technology ...
Zacks Investment Research on MSN
Are medical stocks lagging Brainsway (BWAY) this year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Brainsway Ltd. Sponsored ADR (BWAY) is a stock that can ...
BrainsWay's Q2 results show continued revenue growth and improved cost control. The company is shifting its sales focus to larger institutions and enterprise customers, potentially improving sales ...
BrainsWay Ltd. (NASDAQ:BWAY) stock is trading higher on Monday after the company announced a $20 million investment from Valor Equity Partners. The Details: BrainsWay will issue a total of 2,103,745 ...
Zacks Investment Research on MSN
Recent price trend in Brainsway (BWAY) is your friend, here's why
Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability ...
JERUSALEM, Oct. 01, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ: BWAY, TASE: BWAY), a global leader in the advanced non-invasive treatment of brain disorders, announced today they will be hosting ...
BrainsWay Ltd., the parent company of BrainsWay USA, Inc., and a global leader in the advanced non-invasive treatment of brain disorders, today announces that it has received De Novo clearance from ...
Actively seeking to ramp up this strategic initiative with additional minority equity investments in high-performing mental health providers; partnered with Valor Equity Partners to identify ...
CRESSKILL, N.J. and JERUSALEM, May 05, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments ...
BrainsWay has had a difficult 12 months, as a tough macro environment has overly impacted its customer base, which skews towards smaller companies. A return to growth and a renewed focus on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results